Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC DATABASE   /   MOBILE APP  /  CELEBRITY VCs   /   VENTURE TRACKR   /   ARCHIVE   /   ABOUT US
VC-funded Company:


Icosavax
2815 Eastlake Ave E, Suite 300
Seattle, WA 98102
http://www.icosavax.com/

Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs and reduce healthcare costs. The company was founded on breakthrough computationally-designed virus like particle technology, exclusively licensed for a variety of infectious disease indications from the Institute for Protein Design at the University of Washington.

Key Contact
NameTitleE-Mail
Adam SimpsonCEOadam.simpson@icosavax.com


Funding Events
DateAmountTypeInvestors
10/03/19$51,000,000Series A Adams Street Partners
NanoDimension
Qiming Venture Partners  
Sanofi Ventures
 
Massinvestor/VC News Daily
617-620-4606


© 2018 Massinvestor, Inc.